Table of Contents

company-logo

Alimera Sciences, Inc., a pharmaceutical company, engages in the development and commercialization of ophthalmic pharmaceuticals in the United States and internationally. It offers ILUVIEN, an intravitreal implant for the treatment of diabetic macular edema (DME), which is a disease of the retina that affects individuals with diabetes and lead to severe vision loss and blindness; and to prevent relapse in recurrent non-infectious uveitis affecting the posterior segment of the eye. The company sells its products to physician offices, pharmacies, and hospitals through direct sales and distributors. It has a collaboration agreement with EyePoint Pharmaceuticals US, Inc. for the development and sale of insert technology to deliver other corticosteroids to the back of the eye for the treatment and prevention of eye diseases in humans or to treat diabetic macular edema. The company was incorporated in 2003 and is headquartered in Alpharetta, Georgia.

Alimera Sciences Dividend Announcement

• Alimera Sciences does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Alimera Sciences dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Alimera Sciences Dividend History

Alimera Sciences Dividend Yield

Alimera Sciences current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Alimera Sciences stock? Use our calculator to estimate your expected dividend yield:

Alimera Sciences Financial Ratios

P/E ratio-20.50
PEG ratio1.35
P/B ratio7.77
ROE-33.70%
Payout ratio-8.57%
Current ratio2.79
Quick ratio2.62
Cash Ratio0.55

Alimera Sciences Dividend FAQ

Does Alimera Sciences stock pay dividends?
Alimera Sciences does not currently pay dividends to its shareholders.
Has Alimera Sciences ever paid a dividend?
No, Alimera Sciences has no a history of paying dividends to its shareholders. Alimera Sciences is not known for its dividend payments.
Why doesn't Alimera Sciences pay dividends?
There are several potential reasons why Alimera Sciences would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Alimera Sciences ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Alimera Sciences has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Alimera Sciences a dividend aristocrat?
Alimera Sciences is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Alimera Sciences a dividend king?
Alimera Sciences is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Alimera Sciences a dividend stock?
No, Alimera Sciences is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Alimera Sciences stocks?
To buy Alimera Sciences you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Alimera Sciences stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.